JESSICA MURRAY: Open Payments
NPI 1710421425 · LAKE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 69 payments from 17 companies in 2025. Trend: 2023 $1,437 · 2024 $2,008 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $220 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $169 |
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $140 |
| PFIZER INC. | 9 | $137 |
| IBSA Pharma Inc. | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| Lundbeck LLC | 3 | $50 |
| Organogenesis Inc. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
Products named: JARDIANCE, FARXIGA, CAPLYTA, Rybelsus, NURTEC ODT, REXULTI, Ozempic, Tirosint.
Industry payments across FL — which companies pay providers there.
